Author:
Menni Cristina,Klaser Kerstin,May Anna,Polidori Lorenzo,Capdevila Joan,Louca Panayiotis,Sudre Carole H,Nguyen Long H,Drew David A,Merino Jordi,Hu Christina,Selvachandran Somesh,Antonelli Michela,Murray Benjamin,Canas Liane S,Molteni Erika,Graham Mark S,Modat Marc,Joshi Amit D,Mangino Massimo,Hammers Alexander,Goodman Anna L,Chan Andrew T,Wolf Jonathan,Steves Claire J,Valdes Ana M,Ourselin Sebastien,Spector Tim D
Funder
National Institutes of Health
Wellcome Trust
Chronic Disease Research Foundation
Medical Research Council
Alzheimer's Society
Reference23 articles.
1. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020
2. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021
3. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of “real-world” vaccination outcomes from Israel;Hunter;medRxiv,2021
4. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021
5. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial;Ramasamy;Lancet,2021
Cited by
825 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献